Paul Ivsin is Director, Clinical Trial Offerings, IMS Health and was formerly VP, Consulting Director at CAHG Clinical Trials. A renowned expert on study enrollment strategies and patient engagement, he writes on clinical trial issues at Placebo Lead-In and Placebo Control.